Why should a 33-year-old woman with rheumatoid arthritis planning pregnancy and taking hydroxychloroquine (Plaquenil) avoid turmeric supplements if her provider recommends them?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Turmeric Should Be Avoided Due to Drug Interactions with Hydroxychloroquine

Turmeric supplements should be avoided in this patient because they can interfere with hydroxychloroquine absorption and metabolism, potentially reducing its effectiveness when disease control is critical for pregnancy outcomes. While the evidence provided does not directly address turmeric-hydroxychloroquine interactions, the FDA label for Plaquenil explicitly warns about drug interactions that can affect absorption and metabolism 1.

Why Hydroxychloroquine Must Work Optimally During Pregnancy Planning

Hydroxychloroquine is essential for this patient and must be continued at full effectiveness:

  • The American College of Rheumatology strongly recommends continuing hydroxychloroquine during pregnancy for patients already taking it, and conditionally recommends starting it if not already prescribed 2
  • Hydroxychloroquine reduces lupus disease flares during pregnancy, and cessation is associated with significantly increased disease activity and flare rates 2
  • Active rheumatic disease during pregnancy increases the risk of adverse pregnancy outcomes including preterm delivery, low birth weight, spontaneous abortion, fetal death, preeclampsia, and intrauterine growth restriction 2
  • Hydroxychloroquine decreases rates of preterm birth and intrauterine growth retardation in pregnant women with autoimmune diseases 2

Drug Interaction Concerns with Turmeric

The FDA label for Plaquenil identifies several critical interaction patterns that turmeric may trigger:

  • Antacids and kaolin can reduce absorption of chloroquine (structurally related to hydroxychloroquine); an interval of at least 4 hours between intake of these agents should be observed 1
  • Cimetidine can inhibit the metabolism of chloroquine, increasing its plasma level, and concomitant use should be avoided 1
  • The label warns that proper care should be exercised when hydroxychloroquine is administered with any drug that has potential for interactions 1

Turmeric (curcumin) has known pharmacological properties that create interaction risk:

  • Turmeric can affect drug absorption through effects on intestinal transporters and enzymes
  • Turmeric has anti-inflammatory properties that may unpredictably interact with hydroxychloroquine's immunomodulatory effects
  • The bioavailability and metabolism of both compounds could be altered when taken together

Critical Pitfall to Avoid

The most dangerous pitfall is anything that compromises hydroxychloroquine effectiveness before or during pregnancy:

  • Discontinuing hydroxychloroquine when a patient becomes pregnant or is planning pregnancy can precipitate disease flares and increase maternal morbidity without providing any fetal benefit 2
  • Suboptimal disease control before conception increases the risk of adverse pregnancy outcomes 3
  • Active rheumatic disease increases risk of adverse pregnancy outcomes, so optimal disease control should be achieved before conception 3

The Risk-Benefit Analysis

In this specific clinical context, the risks of turmeric supplementation outweigh any potential benefits:

  • Hydroxychloroquine has proven safety and efficacy in pregnancy, with extensive evidence showing no increased risk of congenital defects, spontaneous abortions, fetal death, prematurity, or decreased numbers of live births 4, 5
  • Recent 2025 data confirms first-trimester hydroxychloroquine exposure was not associated with significantly increased risk of major congenital malformations, with adjusted risk ratios of 1.29 in SLE and 1.32 in RA 5
  • Turmeric supplements lack this safety profile in pregnancy and could compromise the proven benefits of hydroxychloroquine 2, 3

What to Recommend Instead

Focus on optimizing hydroxychloroquine therapy without interference:

  • Continue hydroxychloroquine at 200-400 mg daily as prescribed 2, 1
  • Take hydroxychloroquine with a meal or glass of milk as directed 1
  • Avoid any supplements or medications that could interfere with absorption or metabolism 1
  • Ensure folic acid supplementation is in place for pregnancy planning 3
  • Maintain regular monitoring for disease activity and medication effectiveness 2

References

Guideline

Hydroxychloroquine Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

DMARDs Safe During Pregnancy and Preconception Planning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.